CM
SANA icon

Capula Management’s Sana Biotechnology SANA Stock Holding History

Capula Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-152,990
Closed -$604K – 904
2022
Q4 		$604K Buy
+152,990
New +$748K 0.01% 538

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Capula Management's SANA Position: Q1 2023 in Review

Capula Management sold out of Sana Biotechnology (SANA) in Q1 2023, closing a stake of 152,990 shares — an estimated $604K sold.

Capula Management first reported a position in SANA in Q4 2022 and held it in 1 quarter. The position peaked at $604K in Q4 2022. 120 funds tracked by Wall St. Rank hold SANA as of Q1 2023.

  • Capula Management reported no remaining Sana Biotechnology position as of Q1 2023 after selling out during the quarter.
  • Capula Management sold 152,990 Sana Biotechnology shares in Q1 2023, an estimated $604K.
  • Capula Management first reported a position in Sana Biotechnology in Q4 2022 and held it in 1 quarter.
  • Capula Management's Sana Biotechnology position peaked at $604K in Q4 2022.
  • 120 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2023.

Based on Capula Management's 13F filing for Q1 2023, filed 10 May 2023.